Lawrence W. Wu

966 total citations
18 papers, 101 citations indexed

About

Lawrence W. Wu is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Lawrence W. Wu has authored 18 papers receiving a total of 101 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Lawrence W. Wu's work include Colorectal Cancer Treatments and Studies (4 papers), Gastric Cancer Management and Outcomes (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Lawrence W. Wu is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Gastric Cancer Management and Outcomes (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Lawrence W. Wu collaborates with scholars based in United States, Taiwan and South Korea. Lawrence W. Wu's co-authors include Meenhard Herlyn, Gao Zhang, Yan Gao, Yuliya V. Katlinskaya, Ireneusz Majsterek, Shuo Qie, Akihiro Yoshida, Kirk A. Staschke, Serge Y. Fuchs and J. Alan Diehl and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Surgery.

In The Last Decade

Lawrence W. Wu

14 papers receiving 100 citations

Peers

Lawrence W. Wu

EPIDE

ONCOL

Victoria Salter United Kingdom

Kyla Foster United States

Zigong Shao China

Sheng Yu United Kingdom

Ingrid Ferreira Belgium

Jinhuan Wu China

Georgi N. Yordanov United States

Yuanfang Zhai China

Emerson Padiernos United States

Riku Egami Japan

Victoria Salter United Kingdom

Lawrence W. Wu

80 ×1.5

18 ×0.5

30 ×0.9

14 ×0.7

EPIDE

57 ×3.0

ONCOL

Citations per year, relative to Lawrence W. Wu Lawrence W. Wu (= 1×) peers Victoria Salter

Countries citing papers authored by Lawrence W. Wu

Since Specialization

Citations

This map shows the geographic impact of Lawrence W. Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence W. Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence W. Wu more than expected).

Fields of papers citing papers by Lawrence W. Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence W. Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence W. Wu. The network helps show where Lawrence W. Wu may publish in the future.

Co-authorship network of co-authors of Lawrence W. Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence W. Wu. A scholar is included among the top collaborators of Lawrence W. Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence W. Wu. Lawrence W. Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Wu, Lawrence W. & Ryan H. Moy. (2025). The complex interplay of antibiotic use and immune checkpoint inhibition. The Oncologist. 30(2).

Oh, Sarah Soyeon, et al.. (2025). Rethinking gastric cancer prevention through an immigrant health lens. Nature Reviews Gastroenterology & Hepatology. 22(9). 600–601.

Wu, Lawrence W., Sharon Wu, Joanne Xiu, et al.. (2025). Multi-omic characterization of early-onset esophagogastric cancer. npj Precision Oncology. 9(1). 241–241.

Moy, Ryan H., et al.. (2025). Phase 2 trial of defactinib in combination with avutometinib in patients with advanced diffuse-type gastric cancer.. Journal of Clinical Oncology. 43(4_suppl). 3 indexed citations

Wu, Lawrence W., Lawrence H. Schwartz, & Susan E. Bates. (2025). Regarding RECIST in retrospective studies. The Oncologist. 30(7).

Song, Junmin, et al.. (2025). Validating Khorana Risk Score in gastric cancer patients on immune checkpoint inhibitors and chemotherapy. Immunotherapy. 17(6). 419–424. 1 indexed citations

Wu, Lawrence W., et al.. (2024). Diffuse Gastric Cancer: A Comprehensive Review of Molecular Features and Emerging Therapeutics. Targeted Oncology. 19(6). 845–865. 5 indexed citations

Nicolson, Norman G., Joseph A. Tandurella, Lawrence W. Wu, et al.. (2024). Patient-derived Organoid Pharmacotyping As A Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcinoma. Annals of Surgery. 2 indexed citations

Wu, Lawrence W., et al.. (2024). Pseudoprogression in a patient with metastatic melanoma treated with PD-1 and LAG-3 inhibition. Melanoma Research. 34(4). 382–385. 1 indexed citations

10.

Wu, Lawrence W., S. M. Qasim Hussaini, Jae W. Lee, et al.. (2022). Transformation of metastatic nonfunctioning pancreatic neuroendocrine tumor into insulinoma—two case reports. 5. 6–6. 2 indexed citations

11.

Wu, Lawrence W., et al.. (2021). P48.15 A Case from a Single-Arm, Phase Two, Open Label Study Assessing Sindilimab Plus Metaformin in Chemotherapy Failed PD-L1 Positive Advanced SCLC. Journal of Thoracic Oncology. 16(3). S505–S506. 2 indexed citations

12.

Wu, Lawrence W., et al.. (2020). Pseudohypophosphatemia In A Patient With Multiple Myeloma. AACE Clinical Case Reports. 6(6). e334–e337. 2 indexed citations

13.

Wu, Lawrence W., Alison Patterson, Veena Rajaram, et al.. (2018). Durable Clinical Response to Larotrectinib in an Adolescent Patient With an Undifferentiated Sarcoma Harboring an STRN-NTRK2 Fusion. JCO Precision Oncology. 2(2). 1–8. 8 indexed citations

14.

Zhang, Dongmei, Gao Zhang, Zhongyi Hu, et al.. (2017). Oncogenic RAS Regulates Long Noncoding RNA Orilnc1 in Human Cancer. Cancer Research. 77(14). 3745–3757. 29 indexed citations

15.

Pytel, Dariusz, Yan Gao, Yuliya V. Katlinskaya, et al.. (2016). PERK Is a Haploinsufficient Tumor Suppressor: Gene Dose Determines Tumor-Suppressive Versus Tumor Promoting Properties of PERK in Melanoma. PLoS Genetics. 12(12). e1006518–e1006518. 39 indexed citations

16.

Wu, Lawrence W., Gao Zhang, & Meenhard Herlyn. (2016). Mitochondrial biogenesis meets chemoresistance in BRAF-mutant melanoma. Molecular & Cellular Oncology. 3(4). e1179381–e1179381. 4 indexed citations

17.

Wu, Lawrence W.. (2004). Economics of antitrust : new issues, questions, and insights. Medical Entomology and Zoology. 2 indexed citations

18.

Jiang, Shan, et al.. (1988). [Clinicopathological study on correlation between advanced schistosomiasis and hepatitis B].. PubMed. 6(3). 189–91. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact